Trial Profile
Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Weight Heparin in Child-Pugh B Cirrhotic Patients: a Randomized Controlled Study
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Liver cirrhosis; Thrombosis
- Focus Therapeutic Use
- Acronyms Childbenox
- 27 Feb 2018 Status changed from recruiting to suspended.
- 16 Jun 2016 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
- 16 Jun 2016 Planned primary completion date changed from 1 Jun 2019 to 1 Jul 2019.